SubjectWell, a patient recruitment platform for clinical trials, announced it raised $35 million in a Series B funding round led by Asset Management Ventures.
Other participants in the round include Bertelsmann and existing investors Healthy Ventures, Windham Venture Partners and Geekdom Fund.
According to Crunchbase, the Texas-based company has raised $46.8 million over seven funding rounds....
Decentralized clinical trial company Curebase is partnering with Meru Health on a three-year clinical trial to study the effectiveness of Meru's 12-week treatment program aimed at reducing depression among primary care patients.
Meru Health's smartphone-based, therapist-guided treatment program targets depression, burnout and anxiety, while Curebase provides a decentralized clinical trial...
Woebot Health, maker of a mental health chatbot, recently appointed Dr. Robbert Zusterzeel as vice president of regulatory science and strategy.
Zusterzeel comes to Woebot from IQVIA, where he served as senior director of U.S. regulatory science and strategy. He'd previously worked at the FDA for nearly 10 years.
"We believe in and have embraced regulation from the start and have expanded our...
Decentralized clinical trial company Curebase raised $40 million in a Series B round led by Industry Ventures.
Acrew Capital, World Innovation Lab, Positive Sum, Gaingels, GGV Capital, Bold Capital and Xfund participated in the funding, which also included a strategic investment from pharma giant Gilead Sciences. The round brings Curebase's total raise to $59 million.
WHAT IT DOES
Curebase offers...
Curebase, a platform for decentralized clinical trials, is partnering with AppliedVR to run five trials to test the effectiveness of virtual reality for treating chronic pain.
The companies said the one-year partnership will focus on studying a self-administered, at-home VR therapy program. Curebase will manage patient recruitment, consent, and engagement, and collect patient-reported outcomes...
Y Combinator’s biannual Demo Day is winding to a close after presentations from dozens of tech entrepreneurs. The Silicon Valley-based accelerator has historically had a hand in the development of numerous healthcare tech startups, and this week’s event seems to be no exception.
According to TechCrunch, 28 percent of the 122 startups that presented at Demo Day fell within the healthcare vertical...
